Successful allogeneic stem cell transplantation in second chronic-phase CML induced by the tyrosine kinase inhibitor nilotinib (AMN107) after blast crisis under imatinib

Bone Marrow Transplant. 2007 Jul;40(1):83-4. doi: 10.1038/sj.bmt.1705683. Epub 2007 Apr 23.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Benzamides
  • Blast Crisis / chemically induced*
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Piperazines / adverse effects*
  • Pyrimidines / adverse effects*
  • Pyrimidines / therapeutic use*
  • Stem Cell Transplantation*
  • Transplantation, Homologous
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • nilotinib